Results per Page:
Fred Hutch expands its research capacity in South Lake Union
Three new buildings will boost recruitment and strengthen science
Mapping tumor cell heterogeneity in castrate-resistant prostate cancer
From the Haffner Lab, Human Biology and Clinical Research Divisions
A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
Multiple myeloma research to be presented at American Society of Hematology annual meeting
Dr. Rahul Banerjee to share insights on reducing financial toxicity, time toxicity and side effects of treatment
Dr. Sita Kugel receives V Foundation Translational Research Award
Grant makes possible a clinical trial of targeted treatment for pancreatic cancer
Dr. Sara Hurvitz joins Fred Hutch, University of Washington
Longtime UCLA breast oncologist and international expert will be senior vice president of the Clinical Research Division
Functionalizing the genome to find novel pancreatic cancer treatments
From the Kemp Lab, Human Biology Division
Structural landscape of DNA and precision medicine, firm handshake
From the Ha lab, Public Health Sciences and Human Biology Divisions
Inspiring Generosity: Gift to Fuel Multifaceted Approach to Discovery
Landmark donation from Bezos family to Fred Hutch will fund multiple scientific priorities, including clinical trials support, translational research capabilities and recruitment
Unlocking more information from liquid biopsies
Dr. Gavin Ha receives $1.5M NIH Director’s New Innovator Award for creative young scientists with high-risk, high-reward projects
Transformative $78M gift to establish new precision oncology institute
Gift will accelerate center’s leadership in the future of cancer research
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
Measure 170 times, cut once: high-throughput drug screening for multiple myeloma
From Dr. Pamela Becker and Dr. David Coffey, Clinical Research Division
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year